Popel AS [Author] - Search Results

Year	Number of Results
1974	1
1978	2
1979	3
1980	2
1981	1
1982	1
1983	1
1986	5
1987	5
1988	5
1989	8
1990	3
1992	2
1993	3
1994	6
1995	3
1996	7
1997	5
1998	10
1999	7
2000	7
2001	8
2002	8
2003	7
2004	8
2005	14
2006	13
2007	25
2008	11
2009	16
2010	10
2011	13
2012	11
2013	12
2014	14
2015	9
2016	7
2017	10
2018	10
2019	13
2020	11
2021	10
2022	9
2023	17

1

Experiment-based computational model predicts that IL-6 classic and trans-signaling exhibit similar potency in inducing downstream signaling in endothelial cells.

Song M, Wang Y, Annex BH, Popel AS. Song M, et al. Among authors: popel as. NPJ Syst Biol Appl. 2023 Sep 21;9(1):45. doi: 10.1038/s41540-023-00308-2. NPJ Syst Biol Appl. 2023. PMID: 37735165 Free PMC article.

2

Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence.

Zhang S, Yuan L, Danilova L, Mo G, Zhu Q, Deshpande A, Bell ATF, Elisseeff J, Popel AS, Anders RA, Jaffee EM, Yarchoan M, Fertig EJ, Kagohara LT. Zhang S, et al. Among authors: popel as. Genome Med. 2023 Sep 18;15(1):72. doi: 10.1186/s13073-023-01218-y. Genome Med. 2023. PMID: 37723590 Free PMC article.

3

Informing virtual clinical trials of hepatocellular carcinoma with spatial multi-omics analysis of a human neoadjuvant immunotherapy clinical trial.

Zhang S, Deshpande A, Verma BK, Wang H, Mi H, Yuan L, Ho WJ, Jaffee EM, Zhu Q, Anders RA, Yarchoan M, Kagohara LT, Fertig EJ, Popel AS. Zhang S, et al. Among authors: popel as. bioRxiv. 2023 Aug 15:2023.08.11.553000. doi: 10.1101/2023.08.11.553000. Preprint. bioRxiv. 2023. PMID: 37645761 Free PMC article.

4

Gel-forming therapeutic peptide exhibits sustained delivery and efficacy in a mouse model of triple-negative breast cancer.

Patil A, Mirando AC, Liatsou I, Sgouros G, Popel AS, Pandey NB. Patil A, et al. Among authors: popel as. Peptides. 2023 Nov;169:171075. doi: 10.1016/j.peptides.2023.171075. Epub 2023 Aug 15. Peptides. 2023. PMID: 37591441 Free PMC article.

5

Uncovering the spatial landscape of molecular interactions within the tumor microenvironment through latent spaces.

Deshpande A, Loth M, Sidiropoulos DN, Zhang S, Yuan L, Bell ATF, Zhu Q, Ho WJ, Santa-Maria C, Gilkes DM, Williams SR, Uytingco CR, Chew J, Hartnett A, Bent ZW, Favorov AV, Popel AS, Yarchoan M, Kiemen A, Wu PH, Fujikura K, Wirtz D, Wood LD, Zheng L, Jaffee EM, Anders RA, Danilova L, Stein-O'Brien G, Kagohara LT, Fertig EJ. Deshpande A, et al. Among authors: popel as. Cell Syst. 2023 Aug 16;14(8):722. doi: 10.1016/j.cels.2023.07.006. Cell Syst. 2023. PMID: 37591207 Free PMC article. No abstract available.

6

Using quantitative systems pharmacology modeling to optimize combination therapy of anti-PD-L1 checkpoint inhibitor and T cell engager.

Anbari S, Wang H, Zhang Y, Wang J, Pilvankar M, Nickaeen M, Hansel S, Popel AS. Anbari S, et al. Among authors: popel as. Front Pharmacol. 2023 Jun 20;14:1163432. doi: 10.3389/fphar.2023.1163432. eCollection 2023. Front Pharmacol. 2023. PMID: 37408756 Free PMC article.

7

A transcriptome-informed QSP model of metastatic triple-negative breast cancer identifies predictive biomarkers for PD-1 inhibition.

Arulraj T, Wang H, Emens LA, Santa-Maria CA, Popel AS. Arulraj T, et al. Among authors: popel as. Sci Adv. 2023 Jun 30;9(26):eadg0289. doi: 10.1126/sciadv.adg0289. Epub 2023 Jun 30. Sci Adv. 2023. PMID: 37390206 Free PMC article.

8

Quantifying Intratumoral Heterogeneity and Immunoarchitecture Generated In-Silico by a Spatial Quantitative Systems Pharmacology Model.

Nikfar M, Mi H, Gong C, Kimko H, Popel AS. Nikfar M, et al. Among authors: popel as. Cancers (Basel). 2023 May 13;15(10):2750. doi: 10.3390/cancers15102750. Cancers (Basel). 2023. PMID: 37345087 Free PMC article.

9

Generating immunogenomic data-guided virtual patients using a QSP model to predict response of advanced NSCLC to PD-L1 inhibition.

Wang H, Arulraj T, Kimko H, Popel AS. Wang H, et al. Among authors: popel as. NPJ Precis Oncol. 2023 Jun 8;7(1):55. doi: 10.1038/s41698-023-00405-9. NPJ Precis Oncol. 2023. PMID: 37291190 Free PMC article.

10

Vascular phenotyping of the invasive front in breast cancer using a 3D angiogenesis atlas.

Bhargava A, Popel AS, Pathak AP. Bhargava A, et al. Among authors: popel as. Microvasc Res. 2023 Sep;149:104555. doi: 10.1016/j.mvr.2023.104555. Epub 2023 May 29. Microvasc Res. 2023. PMID: 37257688 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

323 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

323 results

Results by year